Revo Foods’ first whole-cut vegan salmon filet, made from algae and pea protein, will be available in stores next year.

by NICOLE AXWORTHY

Vienna-based vegan food technology company Revo Foods recently unveiled its first “ultra realistic” whole-cut plant-based salmon, which is expected to launch in stores in early 2023. The new product is made using 3D food printing technology and aims to replicate the eating experience of whole-cut fish filets without the need to harm a single fish.

While the majority of conventional fish is consumed in whole-cut filets, few alternative seafood products have been able to mimic the experience. Revo Foods’ scientific team worked for more than two years researching new process technology and ingredient compositions to develop its first whole-cut vegan salmon filet, dubbed “generation 2.0.” Unlike the products of the first generation, which were mostly made with tofu, the new whole-cut salmon uses pea protein and algae extracts, making it rich in protein and omega-3 fatty acids. It was developed using 3D food printing technology to create a taste and texture that mimics conventional salmon and can be prepared (fried, cooked, and steamed) just like conventional fish. The startup has already filed two patents for new technologies to produce such whole-cut vegan fish products.

Last year, Revo Foods unveiled its first 3D-printed vegan smoked salmon product during a tasting event that took place at Budapest Bagels in Vienna. Called “Salmon With Attitude,” the product looked just like real smoked salmon and was also developed using 3D food printing to recreate the texture and appearance of seafood. Similarly, ingredients such as pea protein, algae extracts, and dietary fibers are combined to create a base that is high in protein, omega 3, and B12. Revo showcased its revolutionary vegan fish in a creamy smoked salmon spread. These first products are already available in 16 European countries, including supermarkets in Austria and Germany.

 A lung-mimicking air sac that was 3d printed in water-based gel.

By Davide Sher

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation working in partnership with 3D Systems Corporation (NYSE: DDD) has produced the world’s most complex 3D printed object – a human lung scaffold – and demonstrated it at the LIFE ITSELF Conference in San Diego. The event was organized and hosted by Dr. Sanjay Gupta and Marc Hodosh and was sponsored by CNN, United Therapeutics, and other prominent corporate leaders in healthcare.

Dr. Martine Rothblatt, United Therapeutics’ Chairperson and Chief Executive Officer and Chuck Hull, 3D Systems’ Co-Founder, Executive Vice President, and Chief Technology Officer for Regenerative Medicine, explained to conference attendees during a presentation entitled What’s the Future of Organ Transplantation? that these 3D printed human lung scaffolds designs consisted of a record 44 trillion voxels that layout 4,000 kilometers of pulmonary capillaries and 200 million alveoli.

Scientists at United Therapeutics plan to cellularize these 3D printed human lung scaffolds with a patient’s own stem cells to create tolerable, transplantable human lungs that should not require immunosuppression to prevent rejection. This latest achievement represents the latest milestone of an ongoing research project that was first made public in 2018.

“Last week, it was exciting to show the public our 3D printed human lung scaffold, but we’re thrilled to share that our 3D printed lung scaffolds are now demonstrating gas exchange in animal models. We are regularly printing lung scaffolds as accurately as driving across the United States and not deviating from a course by more than the width of a human hair,” said Dr. Rothblatt. “With the continued hard work of dedicated scientists and engineers at United Therapeutics and 3D Systems, we hope to have these personalized, manufactured lungs cleared for human trials in under five years.”